Clinical Trial

Danon Disease Natural History Study

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this international observational study is to learn about the natural history of Danon disease in male patients (≥8 years of age) and female patients (8 to 50 years of age).
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2024-01-10; most recent amendment 2026-07-27.
Trial Details
NCT Number NCT06214507
Lead Sponsor Rocket Pharmaceuticals Inc.
Conditions Danon Disease
Enrollment 60 participants
Start Date 2023-12-20
Primary Completion 2029-12 (estimated)
Study Completion 2030-03 (estimated)
Updated on ClinicalTrials.gov 2026-07-28